In the majority of renal clear cell carcinoma cases, the activity of the von Hippel-Lindau tumor suppressor (VHL) protein is lost due to genetic or epigenetic changes in the cancer cell genome. This evidence concerns the gene VHL and clear cell renal carcinoma.